These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9869395)

  • 1. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.
    Löhr HF; Krug S; Herr W; Weyer S; Schlaak J; Wölfel T; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1998 Dec; 18(6):405-13. PubMed ID: 9869395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
    Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
    Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
    Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
    Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
    Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].
    Zhang HH; He Y; Zhao H; Piao WH; Liu MC; Xi HL; Yu M; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1171-6. PubMed ID: 16029590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients.
    Sing GK; Ladhams A; Arnold S; Parmar H; Chen X; Cooper J; Butterworth L; Stuart K; D'Arcy D; Cooksley WG
    J Viral Hepat; 2001 Jan; 8(1):19-29. PubMed ID: 11155148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic variations in precore and cytotoxic T lymphocyte regions in chronic hepatitis B in relationship to interferon responsiveness.
    Shindo M; Okuno T
    Liver; 2000 Apr; 20(2):136-42. PubMed ID: 10847482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
    J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z
    Virol J; 2011 May; 8():199. PubMed ID: 21535873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B.
    Tang Y; Wang J; Zhang Y; Zhuo M; Song L; Tang Z; Zang G; Chen X; Yu Y
    Mol Med Rep; 2016 Oct; 14(4):3315-22. PubMed ID: 27510296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses.
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Jiang D; Wang SX; Wei L; Wang Y
    World J Gastroenterol; 2004 Jun; 10(11):1578-82. PubMed ID: 15162529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
    Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.